Join Index
For Startups
For Investors
For Brands
For Analysts
Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Trevi Therapeutics
3062
Trevi Therapeutics
Technology
Biotechnology
Trevi Therapeutics is a drug development company founded in 2011 focused on developing Nalbuphine ER for the severe chronic itching condition known as pruritus.
Suggest edits
Founded
2011
Raised
$98.1M
Follow us
Companies in the same industry
Checkmate Pharmaceuticals
Falcon Therapeutics
PreciThera, Inc.
SOURCE MOLECULAR CORPORATION
VivaSpire Inc.
Kite Pharma
Dova Pharmaceuticals
Aalto University School of Science and Technology
Altimmune, Inc.
Biocare Medical
Alexa global traffic share
